Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.
Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Clin Infect Dis. 2021 Aug 16;73(4):e934-e937. doi: 10.1093/cid/ciab052.
Current international guidelines on human immunodeficieny virus (HIV) Pre-Exposure Prophylaxis (PrEP) recommend serological screening for syphilis at routine 3-monthly PrEP appointments. The aim of our study was to describe the pattern of clinical presentation of syphilis among men who have sex with men (MSM) taking PrEP. We were interested in whether syphilis is detected through screening at scheduled3-monthly PrEP clinic appointments or whether primary or secondary syphilis presented at unscheduled interval visits.
This was a retrospective study of MSM attending the PrEP clinic at the Melbourne Sexual Health Centre between February 2016 and March 2019. Serological screening for syphilis was routinely undertaken at 3-monthly PrEP clinic appointments. Diagnoses of early syphilis were identified from PrEP clinic visits and from interim walk-in STI clinic attendances.
There were 69 cases of early syphilis among 61 MSM taking PrEP during the study period. There were 24 (35%) primary, 16 (23%) secondary, and 29 (42%) early latent infections. The incidence of early syphilis was 8.6 per 100 person-years. A substantial proportion of primary (58%) and secondary (44%) syphilis diagnoses were made at interim STI clinic attendances, between PrEP appointments.
Syphilis screening at routine 3-monthly PrEP visits alone fails to detect a proportion of primary and secondary syphilis infections and may be insufficient in preventing onward transmission. Education of MSM taking PrEP regarding the risk of syphilis and symptom recognition is necessary together with access to syphilis testing between PrEP visits.
目前关于人类免疫缺陷病毒(HIV)暴露前预防(PrEP)的国际指南建议在常规每 3 个月的 PrEP 预约时进行梅毒血清学筛查。我们研究的目的是描述接受 PrEP 的男男性行为者(MSM)中梅毒的临床表现模式。我们感兴趣的是梅毒是否通过每 3 个月的 PrEP 诊所预约筛查检测到,还是原发性或二期梅毒在非计划间隔就诊时出现。
这是一项对 2016 年 2 月至 2019 年 3 月期间在墨尔本性健康中心接受 PrEP 诊所治疗的 MSM 进行的回顾性研究。梅毒血清学筛查在每 3 个月的 PrEP 诊所预约时进行。早期梅毒的诊断是从 PrEP 诊所就诊和临时走诊性传播感染(STI)诊所就诊中确定的。
在研究期间,有 69 例接受 PrEP 的 MSM 发生了 61 例早期梅毒。有 24 例(35%)为原发性,16 例(23%)为二期,29 例(42%)为早期潜伏感染。早期梅毒的发病率为每 100 人年 8.6 例。相当一部分原发性(58%)和二期(44%)梅毒诊断是在 PrEP 预约之间的临时 STI 诊所就诊时做出的。
仅在常规每 3 个月的 PrEP 就诊时进行梅毒筛查,无法检测到一部分原发性和二期梅毒感染,可能不足以防止进一步传播。需要对接受 PrEP 的 MSM 进行有关梅毒风险和症状识别的教育,并且需要在 PrEP 就诊之间进行梅毒检测。